74 related articles for article (PubMed ID: 10937633)
1. Multidrug resistance-1 gene expression does not increase during tumor progression in the MGH-OGS murine osteosarcoma tumor model.
Trammell RA; Johnson CB; Barker JR; Bell RS; Allan DG
J Orthop Res; 2000 May; 18(3):449-55. PubMed ID: 10937633
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance and malignancy in human osteosarcoma.
Scotlandi K; Serra M; Nicoletti G; Vaccari M; Manara MC; Nini G; Landuzzi L; Colacci A; Bacci G; Bertoni F; Picci P; Campanacci M; Baldini N
Cancer Res; 1996 May; 56(10):2434-9. PubMed ID: 8625324
[TBL] [Abstract][Full Text] [Related]
3. Effect of doxorubicin on local recurrence following marginal resection in the MGH-OGS murine model.
Bell RS; O'Connor G; Bell DF; Jacob J
J Orthop Res; 1990 Jan; 8(1):105-18. PubMed ID: 2293625
[TBL] [Abstract][Full Text] [Related]
4. Multidrug resistance mediated by overexpression of P-glycoprotein in human osteosarcoma in vivo.
Suto R; Abe Y; Nakamura M; Ohnishi Y; Yoshimura M; Lee YH; Imanishi T; Yamazaki H; Kijima H; Tokunaga T; Oshika Y; Hiraoka N; Tamaoki N; Fukuda H; Ueyama Y
Int J Oncol; 1998 Feb; 12(2):287-91. PubMed ID: 9458350
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy and surgery in a murine osteosarcoma.
Bell RS; Jacobs J
J Orthop Res; 1992 Sep; 10(5):720-8. PubMed ID: 1500984
[TBL] [Abstract][Full Text] [Related]
6. Expression of vascular endothelial growth factor-C and its receptor in osteosarcomas.
Park HR; Min K; Kim HS; Jung WW; Park YK
Pathol Res Pract; 2008; 204(8):575-82. PubMed ID: 18440723
[TBL] [Abstract][Full Text] [Related]
7. Reduced folate carrier protein expression in osteosarcoma: implications for the prediction of tumor chemosensitivity.
Ifergan I; Meller I; Issakov J; Assaraf YG
Cancer; 2003 Nov; 98(9):1958-66. PubMed ID: 14584080
[TBL] [Abstract][Full Text] [Related]
8. Osteoblastic differentiation and P-glycoprotein multidrug resistance in a murine osteosarcoma model.
Takeshita H; Kusuzaki K; Murata H; Suginoshita T; Hirata M; Hashiguchi S; Ashihara T; Gebhardt MC; Mankin HJ; Hirasawa Y
Br J Cancer; 2000 Apr; 82(7):1327-31. PubMed ID: 10755409
[TBL] [Abstract][Full Text] [Related]
9. Ezrin in osteosarcoma: comparison between conventional high-grade and central low-grade osteosarcoma.
Park HR; Jung WW; Bacchini P; Bertoni F; Kim YW; Park YK
Pathol Res Pract; 2006; 202(7):509-15. PubMed ID: 16677779
[TBL] [Abstract][Full Text] [Related]
10. Differentially expressed genes in multidrug resistant variants of U-2 OS human osteosarcoma cells.
Chano T; Mori K; Scotlandi K; Benini S; Lapucci C; Manara MC; Serra M; Picci P; Okabe H; Baldini N
Oncol Rep; 2004 Jun; 11(6):1257-63. PubMed ID: 15138564
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of P-glycoprotein, HER-2/ErbB-2, p53, and Bcl-2 in primary tumor and metachronous lung metastases in patients with high-grade osteosarcoma.
Ferrari S; Bertoni F; Zanella L; Setola E; Bacchini P; Alberghini M; Versari M; Bacci G
Cancer; 2004 May; 100(9):1936-42. PubMed ID: 15112275
[TBL] [Abstract][Full Text] [Related]
12. Reversal of multidrug resistance by two nordihydroguaiaretic acid derivatives, M4N and maltose-M3N, and their use in combination with doxorubicin or paclitaxel.
Chang CC; Liang YC; Klutz A; Hsu CI; Lin CF; Mold DE; Chou TC; Lee YC; Huang RC
Cancer Chemother Pharmacol; 2006 Nov; 58(5):640-53. PubMed ID: 16544145
[TBL] [Abstract][Full Text] [Related]
13. [Apoptosis antagonizing transcription factor is a gene highly expressed in highly metastatic human osteosarcoma cell lines].
Yin JN; Fan QY; Hao XB; Yang N
Ai Zheng; 2002 Feb; 21(2):127-31. PubMed ID: 12479059
[TBL] [Abstract][Full Text] [Related]
14. The expression of the urokinase plasminogen activator system in metastatic murine osteosarcoma: an in vivo mouse model.
Fisher JL; Mackie PS; Howard ML; Zhou H; Choong PF
Clin Cancer Res; 2001 Jun; 7(6):1654-60. PubMed ID: 11410503
[TBL] [Abstract][Full Text] [Related]
15. Metastasis-associated differences in gene expression in a murine model of osteosarcoma.
Khanna C; Khan J; Nguyen P; Prehn J; Caylor J; Yeung C; Trepel J; Meltzer P; Helman L
Cancer Res; 2001 May; 61(9):3750-9. PubMed ID: 11325848
[TBL] [Abstract][Full Text] [Related]
16. Expression of P-glycoprotein in high grade osteosarcomas with special emphasis on chondroblastic subtype.
Radig K; Häckel C; Herting J; Oda Y; Mittler U; Neumann W; Roessner A
Gen Diagn Pathol; 1997 Feb; 142(3-4):139-45. PubMed ID: 9065577
[TBL] [Abstract][Full Text] [Related]
17. The expression of P-glycoprotein is causally related to a less aggressive phenotype in human osteosarcoma cells.
Scotlandi K; Manara MC; Serra M; Benini S; Maurici D; Caputo A; De Giovanni C; Lollini PL; Nanni P; Picci P; Campanacci M; Baldini N
Oncogene; 1999 Jan; 18(3):739-46. PubMed ID: 9989824
[TBL] [Abstract][Full Text] [Related]
18. Expression of the melatonin receptor (MT) 1 in benign and malignant human bone tumors.
Toma CD; Svoboda M; Arrich F; Ekmekcioglu C; Assadian O; Thalhammer T
J Pineal Res; 2007 Sep; 43(2):206-13. PubMed ID: 17645699
[TBL] [Abstract][Full Text] [Related]
19. Timing of chemotherapy and surgery in a murine osteosarcoma model.
Bell RS; Roth YF; Gebhardt MC; Bell DF; Rosenberg AE; Mankin HJ; Suit HD
Cancer Res; 1988 Oct; 48(19):5533-8. PubMed ID: 3166399
[TBL] [Abstract][Full Text] [Related]
20. Expression of the multidrug-resistant gene in human musculoskeletal tumors.
Nagata Y; Yamasaki H; Fukuda K; Tanaka S; Tsuruo T; Shuntoh H; Kuno T
J Environ Pathol Toxicol Oncol; 1992; 11(3):131-7. PubMed ID: 1352546
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
